Altre lingue 4basebio PLC

Azioni

Mercato chiuso - London S.E. Altri mercati azionari 17:35:21 30/04/2024			Variaz. 5gg	Var. 1 gen.
1.070 ^GBX	0,00%		+2,39%	+57,35%

10/04	4basebio fornirà DNA sintetico per il programma di vaccino mRNA	AN
10/04	4Basebio plc annuncia la fornitura dei suoi prodotti opDNA? nel programma di vaccini di un cliente farmaceutico di livello 1	CI

4basebio to supply synthetic DNA for mRNA vaccine program	10/04
4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program	10/04
4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	10/04
4basebio updates markets on "key milestone" with client	21/03
4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine	21/03
Alpha Real Trust says in "robust" financial shape	01/03
4basebio wins DNA supply contract to support RNA therapies	01/03
4basebio Wins Synthetic DNA Supply Tender from CPI	01/03
4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence	01/03
4basebio Plc - Holding(s) in Company	06/02
4basebio Plc - Holding(s) in Company	06/02
4basebio Plc - Holding(s) in Company	06/02
4basebio Plc - Holding(s) in Company	06/02
4basebio Plc - Exercise of Options	06/02
4basebio Plc - Holding(s) in Company	05/02
4basebio Plc - Holding(s) in Company	05/02
4basebio Plc - Holding(s) in Company	05/02
4basebio Plc - Directors' Dealings	05/02
4basebio Plc - Long-Term Incentive Plan and Exercise of Options	02/02
4basebio interim loss widens as research costs increase	21/09/23

Non ci sono risultati per questa ricerca